Biomarkers for ovarian cancer risk assessment

Not Applicable

Completed

• Conditions: Ovarian cancer; Cancer; Malignant neoplasm of ovary

• Registration Number: ISRCTN13470572
• Lead Sponsor: niversity of Manchester

Brief Summary

2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35565253/ (added 04/07/2022) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34036134/ (added 31/08/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-13
• Study Completion: 2021-03-05
• Last Update Posted: 12 September 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 1375

Inclusion Criteria

Phase 1:
1. Women undergoing GP requested CA125 testing where the sample is processed by MFT
2. Aged over 18

Phase 2:
1. Women who underwent initial CA125 and HE4 testing in phase 1 who are subsequently referred for further tests or treatment
2. Ability to provide informed consent
3. Aged over 18 years

Exclusion Criteria

Phase 2:
Inability to provide informed consent

Study & Design

• Study Type: Observational
• Study Design: Not specified